Package 72789-023-30

Brand: levocetirizine dihydrochloride

Generic: levocetirizine dihydrochloride
NDC Package

Package Facts

Identity

Package NDC 72789-023-30
Digits Only 7278902330
Product NDC 72789-023
Description

30 TABLET in 1 BOTTLE, PLASTIC (72789-023-30)

Marketing

Marketing Status
Marketed Since 2019-10-17
Brand levocetirizine dihydrochloride
Generic levocetirizine dihydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2d58a1fb-47b6-e4c8-e063-6294a90ad5f3", "openfda": {"upc": ["0372789023304"], "unii": ["SOD6A38AGA"], "rxcui": ["855172"], "spl_set_id": ["57c7c673-790c-4158-87ca-7d8fb68c4286"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (72789-023-30)", "package_ndc": "72789-023-30", "marketing_start_date": "20191017"}], "brand_name": "Levocetirizine Dihydrochloride", "product_id": "72789-023_2d58a1fb-47b6-e4c8-e063-6294a90ad5f3", "dosage_form": "TABLET", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "72789-023", "generic_name": "Levocetirizine Dihydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levocetirizine Dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA091264", "marketing_category": "ANDA", "marketing_start_date": "20120629", "listing_expiration_date": "20261231"}